Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony B El-Khoueiry

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cancer Investigation|February 10, 2006
Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?Anthony B El-Khoueiry, Heinz-Josef Lenz
Hepatology (Baltimore, Md.)|June 10, 2020
Liver Cancer ImmunitySumera I Ilyas, Juan Wang, Anthony B El-Khoueiry
Cancer|October 28, 2008
Rates and predictors of chemotherapy use for stage III colon cancer: a systematic reviewDavid A Etzioni, Anthony B El-Khoueiry, Robert W Beart
Cancer Treatment Reviews|May 24, 2021
Cabozantinib: An evolving therapy for hepatocellular carcinomaAnthony B El-Khoueiry, Diana L Hanna, Josep Llovet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Therapeutic Advances in Medical Oncology|August 11, 2021
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancerStephen P Hack, Wendy Verret, Sohail Mulla, et al.
BMC Cancer|April 10, 2022
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trialAnthony B El-Khoueiry, Tim Meyer, Ann-Lii Cheng, et al.
Clinical and Translational Science|May 11, 2023
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, et al.
JMIR Research Protocols|October 3, 2018
Monitoring Twitter Conversations for Targeted Recruitment in Cancer Trials in Los Angeles County: Protocol for a Mixed-Methods Pilot StudyKatja Reuter, Praveen Angyan, NamQuyen Le, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancerAnthony B El-Khoueiry, John Sarantopoulos, Cindy L O'Bryant, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cancer Investigation|February 10, 2006
Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?Anthony B El-Khoueiry, Heinz-Josef Lenz
Hepatology (Baltimore, Md.)|June 10, 2020
Liver Cancer ImmunitySumera I Ilyas, Juan Wang, Anthony B El-Khoueiry
Cancer|October 28, 2008
Rates and predictors of chemotherapy use for stage III colon cancer: a systematic reviewDavid A Etzioni, Anthony B El-Khoueiry, Robert W Beart
Cancer Treatment Reviews|May 24, 2021
Cabozantinib: An evolving therapy for hepatocellular carcinomaAnthony B El-Khoueiry, Diana L Hanna, Josep Llovet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Therapeutic Advances in Medical Oncology|August 11, 2021
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancerStephen P Hack, Wendy Verret, Sohail Mulla, et al.
BMC Cancer|April 10, 2022
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trialAnthony B El-Khoueiry, Tim Meyer, Ann-Lii Cheng, et al.
Clinical and Translational Science|May 11, 2023
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, et al.
JMIR Research Protocols|October 3, 2018
Monitoring Twitter Conversations for Targeted Recruitment in Cancer Trials in Los Angeles County: Protocol for a Mixed-Methods Pilot StudyKatja Reuter, Praveen Angyan, NamQuyen Le, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancerAnthony B El-Khoueiry, John Sarantopoulos, Cindy L O'Bryant, et al.
Pageof 6